6 years ago
1
Pharmaceutical companies are backing away from a growing threat that could kill 10 million people a year by 2050
Just two years after Novartis announced it would embrace the challenge of searching for cures for life-threatening infections known as superbugs, the drugmaker said last week it would exit antibacterial and antiviral research.
Continue Reading
https://www.businessinsider.com.au
Join the Discussion
Well,I suspected this would be happening. We brought this mess on ourselves and it sure does not look good for us.